2022
DOI: 10.1021/acsbiomaterials.2c00766
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy Evaluation of SDF-1α-Based Polypeptides in an Acute Myocardial Infarction Model Using Structure-Based Drug Design

Abstract: Stromal cell-derived factor-1 alpha (SDF-1α, CXCL12) mediates the migration of circulating cells to desired sites for tissue development, homeostasis, and regeneration and can be used to promote cardiac regeneration by recruiting stem cells. However, the use of SDF-1α in the injured heart necessitates not only higher binding affinity to its receptor, CXCR4+, but also better robustness against enzymatic degradation than other SDF-1 isoforms. Here, we conduct a screening of SDF-1α analog peptides that were desig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 41 publications
0
0
0
Order By: Relevance
“…One of these analogue peptides, SDP-4, promoted cardiac regeneration in myocardial infarction animals more than native SDF-1α. The results confirm that the SDP-4 peptide is an excellent candidate for cardiac regeneration in acute myocardial infarction 181 .…”
Section: Discussionsupporting
confidence: 74%
“…One of these analogue peptides, SDP-4, promoted cardiac regeneration in myocardial infarction animals more than native SDF-1α. The results confirm that the SDP-4 peptide is an excellent candidate for cardiac regeneration in acute myocardial infarction 181 .…”
Section: Discussionsupporting
confidence: 74%